UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
AMENDMENT NO. 1 TO
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Q-MED, INC.
-----------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE PER SHARE
---------------------------------------
(Title of Class of Securities)
74791410
---------------------
(CUSIP Number)
Bruce F. Wesson
Senior Managing Member
Claudius, L.L.C.
610 Fifth Avenue, 5th Floor
New York, NY 10020
(212) 218-4990
--------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
NOVEMBER 16, 1998
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this Schedule because of Rule 13d-
1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other
parties to whom copies are to be sent.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934, as amended (the "Act") or
otherwise subject to the liabilities of that section of the Act
but shall be subject to all provisions of the Act (however, see
the Notes).
Page 1 of 17 Pages
<PAGE>
Pages 2 through 9 of the initial Schedule 13D pertaining to the
Common Stock of Q-Med, Inc., a Delaware corporation, filed with
the Securities and Exchange Commission ("SEC") on March 30, 1998
for an event on March 18, 1998 (the "Initial Schedule 13D") are
hereby amended to read in their entirety as follows:
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 2 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Partners III, L.P.
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
2,177,634 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
2,177,634
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,177,634
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
17.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 3 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Partners International III, L.P.
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
197,113 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
197,113
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
197,113
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.5%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 4 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Employee Fund III, L.P.
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
9,477 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
9,477
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,477
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 5 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William R. Grant
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
13,334 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
13,334
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,334
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 6 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bruce F. Wesson
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
38,333 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
38,333
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
38,333
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.3%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 7 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
L. John Wilkerson
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
38,333 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
38,333
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
38,333
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.3%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 8 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Srini Conjeevaram
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
India (see Item 2)
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
9,000 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
9,000
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,000
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 9 OF 17 PAGES
------------- --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
David Jahns
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
9,000 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
9,000
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,000
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
ITEM 1. SECURITY AND ISSUER.
The first paragraph of Item 1 of the Initial Schedule 13D
is hereby amended to read in its entirety as follows:
This statement covers a total of 2,492,224 fully diluted
shares of Common Stock, $.001 par value per share (the "Common
Stock"), of Q-Med, Inc., a Delaware corporation (the "Issuer").
The Reporting Persons (as defined in Item 2 hereof) as of the
date hereof hold an aggregate of (i) 1,315,363 shares of Common
Stock (the "Common Shares"), (ii) $950,000 principal amount of
Convertible Notes of the Issuer (the "Notes"), which as of
the date hereof are convertible into an aggregate of 568,861
shares of Common Stock, and (iii) warrants for the purchase of
607,999 shares of Common Stock (the "Warrants"), which as of the
date hereof may be exercised for an aggregate of 607,999 shares
of Common Stock. The Common Shares, Notes and Warrants are
referred to herein, collectively, as the "Securities".
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item 3 of the Initial Schedule 13D is hereby amended to
read in its entirety as follows:
The funds for the acquisition of the Common Shares were
allocated from the working capital of the Partnership Reporting
Persons and were not obtained by means of a loan or other
borrowing arrangement.
The Common Shares were acquired by the Partnership Reporting
Persons at a purchase price of $1.67 per share for an aggregate
amount of $1,000,000 in cash plus the exchange of approximately
$1,200,000 amount of principal and accrued interest on Notes of
the Issuer held by them. The Warrants, which are exercisable at
a price equal to the average of the market price of the Issuer's
common stock for the ten trading days following issuance, were
issued as partial consideration for the exchange by the Partnership
Reporting Persons of the aforesaid convertible notes held by them.
Each of the Partnership Reporting Persons paid its pro rata share
of the acquisition price of the Common Shares based upon the number
of Common Shares it received.
-10-
<PAGE>
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5, subpart (a) of the Initial Schedule 13D is hereby
amended to read in its entirety as follows:
(a) Each Reporting Person owns or has the right to acquire
the number of securities shown opposite its name:
=======================================================================
(1) (2) (3) (4) (5) (6)
Number
of
Shares
of
Common
Stock
which
Number of may be
Shares of acquired Percentage of
Number of Common pursuant Outstanding
Shares of Stock into to Total of Shares of
Common which Owned exercise Columns Common Stock
Reporting Stock Notes are of Owned (2), (3) (see Note
Person Owned Convertible Warrants and (4) below)
-----------------------------------------------------------------------
Galen 1,201,389 519,570 456,675 2,177,634 17.1%
-----------------------------------------------------------------------
Galen Intl 108,746 47,030 41,337 197,113 1.5%
-----------------------------------------------------------------------
GEF 5,228 2,261 1,988 9,477 0.1%
-----------------------------------------------------------------------
Grant 0 0 13,334 13,334 0.1%
-----------------------------------------------------------------------
Wesson 0 0 38,333 38,333 0.3%
-----------------------------------------------------------------------
Wilkerson 0 0 38,333 38,333 0.3%
-----------------------------------------------------------------------
Conjeevaram 0 0 9,000 9,000 0.1%
-----------------------------------------------------------------------
Jahns 0 0 9,000 9,000 0.1%
-----------------------------------------------------------------------
Total 1,315,363 568,861 608,000 2,492,224 19.5%
=======================================================================
Note: The percentages shown in each row of column (6) were
calculated, for each respective row, by (i) adding the totals in
the bottom row of columns (3) and (4) to 11,586,221 (the number
of shares of Common Stock outstanding as of November 16, 1997,
such number having been provided by the Issuer to the Reporting
Persons) (the "Total Adjusted Outstanding Shares"), then (ii)
dividing the amount in column (5) by the Total Adjusted
Outstanding Shares, and then (iii) expressing such quotient in
terms of a percentage.
-11-
<PAGE>
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Item 7 of the Initial Schedule 13D is hereby amended to
add the folowing Exhibit 2:
2. Joint Filing Agreement and Power of Attorney, dated
November 23, 1998, by the Reporting Persons and the Related Persons.
-12-
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in the statement
is true, complete and correct.
Date: November 23, 1998 GALEN PARTNERS III, L.P.
By: Claudius, L.L.C.
By: /s/ Bruce F. Wesson
-----------------------------
Senior Managing Member
GALEN PARTNERS
INTERNATIONAL III, L.P.
By: Claudius, L.L.C.
By: /s/ Bruce F. Wesson
-----------------------------
Senior Managing Member
GALEN EMPLOYEE FUND III, L.P.
By: Wesson Enterprises, Inc.
By: /s/ Bruce F. Wesson
-----------------------------
President
[Signatures continued on next page.]
-13-
<PAGE>
/s/ William R. Grant
--------------------------------
WILLIAM R. GRANT
/s/ Bruce F. Wesson
--------------------------------
BRUCE F. WESSON
/s/ L. John Wilkerson
--------------------------------
L. JOHN WILKERSON
/s/ David Jahns
--------------------------------
DAVID JAHNS
/s/ Srini Conjeevaram
--------------------------------
SRINI CONJEEVARAM
/s/ Zubeen Shroff
--------------------------------
ZUBEEN SHROFF
CLAUDIUS, L.L.C.
By: /s/ Bruce F. Wesson
------------------------------
Senior Managing Member
WESSON ENTERPRISES, INC.
By: /s/ Bruce F. Wesson
------------------------------
President
-14-
<PAGE>
EXHIBIT INDEX
Exhibit Description
------- -----------
2 Joint Filing Agreement and Power of
Attorney, dated November 23, 1998,
by the Reporting Persons and the
Related Persons
-15-
Exhibit 2
JOINT FILING AGREEMENT
----------------------
AND POWER OF ATTORNEY
---------------------
In accordance with Rule 13d-1(f) under the Securities
Exchange Act of 1934, the persons named below agree to the joint
filing on behalf of each of them of a Statement on Schedule 13D
(including exhibits and thereto) with respect to the acquisition
of, or the right to acquire, the Common Stock of Q-Med, Inc. a
Delaware corporation. This Agreement shall be included as an
Exhibit to such joint filing. In evidence thereof, each of the
undersigned, being duly authorized, hereby executes this
Agreement as of the 23rd day of November, 1998.
Each person whose signature appears below hereby constitutes
and appoints Bruce F. Wesson as his or its true and lawful
attorney-in-act and agent, with full power and authority,
including power of substitution and resubstitution, and in his or
its name, place and stead in any and all capacities, to execute
in the name of each such person, and to file, with all exhibits
thereto and other documents in connection therewith, with the
Securities and Exchange Commission, any and all amendments to
this Statement on Schedule 13D as such attorney-in-fact and
agent, or its substitutes, executing such amendments deem
necessary or advisable to enable each person whose signature
appears below to comply with the Securities Exchange Act of 1934
and any rules, regulations and requirements of the Securities and
Exchange Commission in respect thereof, granting to said
attorney-in-fact, agents and substitutes full power and authority
to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all
intends and purposes as they might or cold do in person, and does
hereby ratify and confirm all that such attorney-in-fact, agents
or substitutes, or any of the separately, may lawfully do os
cause to b done by virtue thereof.
GALEN PARTNERS III, L.P.
By: Claudius, L.L.C.
By: /s/ Bruce F. Wesson
-----------------------------
Senior Managing Member
GALEN PARTNERS
INTERNATIONAL III, L.P.
By: Claudius, L.L.C.
By: /s/ Bruce F. Wesson
-----------------------------
Senior Managing Member
-16-
<PAGE>
GALEN EMPLOYEE FUND III, L.P.
By: Wesson Enterprises, Inc.
By: /s/ Bruce F. Wesson
-----------------------------
President
/s/ William R. Grant
--------------------------------
WILLIAM R. GRANT
/s/ Bruce F. Wesson
--------------------------------
BRUCE F. WESSON
/s/ L. John Wilkerson
--------------------------------
L. JOHN WILKERSON
/s/ David Jahns
--------------------------------
DAVID JAHNS
/s/ Srini Conjeevaram
--------------------------------
SRINI CONJEEVARAM
/s/ Zubeen Shroff
--------------------------------
ZUBEEN SHROFF
CLAUDIUS, L.L.C.
By: /s/ Bruce F. Wesson
------------------------------
Senior Managing Member
WESSON ENTERPRISES, INC.
By: /s/ Bruce F. Wesson
------------------------------
President
-17-
